(Q41107960)

26 September 2017

1 reference

title

A risk-benefit assessment of sulpiride in the treatment of schizophrenia (English)

1 reference

26 September 2017

0 references

M C Mauri

1

1 reference

26 September 2017

S Bravin

2

1 reference

26 September 2017

A Bitetto

3

1 reference

26 September 2017

R Rudelli

4

1 reference

26 September 2017

G Invernizzi

5

1 reference

26 September 2017

1 May 1996

1 reference

26 September 2017

11

1 reference

inferred from page(s)

published in

Drug Safety

1 reference

26 September 2017

14

1 reference

26 September 2017

5

1 reference

26 September 2017

288-298

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199614050-00003

26 September 2017

0 references

cites work

Sulpiride and perphenazine in schizophrenia. A double-blind clinical trial

1 reference

12 December 2020

Sulpiride: an antipsychotic with selective dopaminergic antagonist properties

1 reference

12 December 2020

Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial

1 reference

12 December 2020

Neuroleptic withdrawal in schizophrenic patients

1 reference

12 December 2020

Study of the clinical effects of sulpiride and perphenazine in 82 schizophrenic patients by the double blind method

1 reference

12 December 2020

Chemical brain anatomy in schizophrenia.

1 reference

12 December 2020

'Akinetic Depression' in Schizophrenia

1 reference

12 December 2020

The importance of pharmacokinetic data on sulpiride: results of a bioequivalence study of two sulpiride 200 mg preparations following oral administration.

1 reference

12 December 2020

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

12 December 2020

Levosulpiride: a review of its clinical use in psychiatry

1 reference

12 December 2020

Cross-over comparison of the therapeutic effects of sulpiride and perphenazine in schizophrenic and schizoaffective psychoses

1 reference

12 December 2020

Tardive dyskinesia induced by sulpiride

1 reference

12 December 2020

Risks and implications of interrupting maintenance psychotropic drug therapy.

1 reference

12 December 2020

Risperidone in the treatment of schizophrenia

1 reference

12 December 2020

Antideficit properties of neuroleptics.

1 reference

12 December 2020

Defining treatment refractoriness in schizophrenia

1 reference

12 December 2020

Comparison of sulpiride and chlorpromazine in psychoses. A double-blind multicentre study

1 reference

12 December 2020

[Long-term dogmatil therapy in major psychiatry]

1 reference

12 December 2020

Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations

1 reference

12 December 2020

Controlled trial of sulpiride in chronic schizophrenic patients

1 reference

12 December 2020

Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans

1 reference

12 December 2020

The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.

1 reference

12 December 2020

[An original psychotropic drug: sulpiride]

1 reference

12 December 2020

L-sulpiride in young and elderly negative schizophrenics: clinical and pharmacokinetic variables

1 reference

12 December 2020

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

12 December 2020

Do negative symptoms respond to pharmacological treatment?

1 reference

12 December 2020

The substituted benzamides - a novel class of dopamine antagonists

1 reference

12 December 2020

Pharmacokinetics of sulpiride after intravenous administration in patients with impaired renal function.

1 reference

12 December 2020

Specific receptors for substituted benzamide drugs in brain.

1 reference

12 December 2020

Sulpiride versus haloperidol, a clinical trial in schizophrenia. A preliminary report

1 reference

12 December 2020

A clinical and pharmacodynamic evaluation of sulpiride

1 reference

12 December 2020

Effects of sulpiride and oxypertine on the dopaminergic system in the rat striatum

1 reference

12 December 2020

Clinical Evaluation of Sulpiride in Schizophrenic Patients - A Double-blind Comparison with Chlorpromazine

1 reference

12 December 2020

Clinico-pharmacological studies of sulpiride

1 reference

12 December 2020

The effect of sulpiride on negative symptoms of schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

Sulpiride in tardive dyskinesia

1 reference

12 December 2020

1 reference

12 December 2020

An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels

1 reference

12 December 2020

Pharmacokinetics of sulpiride in humans after intravenous and intramuscular administrations

1 reference

12 December 2020

The pharmacokinetics of intravenous and oral sulpiride in healthy human subjects

1 reference

12 December 2020

Relationships Between Drug Concentrations in Serum and CSF, Clinical Effects and Monoaminergic Variables in Schizophrenic Patients Treated with Sulpiride or Chlorpromazine

1 reference

12 December 2020

Neuroleptic-induced prolactin rise: influence of pharmacological alterations of different neurotransmitter system.

1 reference

12 December 2020

The distinction of positive and negative symptoms. The failure of a two-dimensional model

1 reference

12 December 2020

Possible mechanism of antidepressant effect of L-sulpiride

1 reference

12 December 2020

Effects of food intake and meal size on the bioavailability of sulpiride in two dosage forms.

1 reference

12 December 2020

Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations

1 reference

12 December 2020

Prophylactic effects of neuroleptics in symptom-free schizophrenics: a comparative dose-response study of timiperone and sulpiride

1 reference

12 December 2020

Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients

1 reference

12 December 2020

Striatal and nucleus accumbens D1/D2 dopamine receptors in neuroleptic catalepsy.

1 reference

12 December 2020

Sulpiride-induced tardive dystonia

1 reference

12 December 2020

A Double‐Blind Comparison of Sulpiride with Chlorpromazine in Chronic Schizophrenia

1 reference

12 December 2020

10.2165/00002018-199614050-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

26 September 2017

0 references

1 reference